Compare ADP & BMY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ADP | BMY |
|---|---|---|
| Founded | 1949 | 1887 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | EDP Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 102.9B | 95.0B |
| IPO Year | N/A | N/A |
| Metric | ADP | BMY |
|---|---|---|
| Price | $264.93 | $54.55 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 12 | 13 |
| Target Price | ★ $312.25 | $56.31 |
| AVG Volume (30 Days) | 2.2M | ★ 15.2M |
| Earning Date | 01-28-2026 | 10-30-2025 |
| Dividend Yield | 2.56% | ★ 4.81% |
| EPS Growth | ★ 8.22 | N/A |
| EPS | ★ 10.13 | 2.97 |
| Revenue | $20,903,400,000.00 | ★ $48,034,000,000.00 |
| Revenue This Year | $6.88 | $0.23 |
| Revenue Next Year | $5.78 | N/A |
| P/E Ratio | $26.27 | ★ $17.64 |
| Revenue Growth | ★ 7.07 | 1.26 |
| 52 Week Low | $247.18 | $42.52 |
| 52 Week High | $329.93 | $63.33 |
| Indicator | ADP | BMY |
|---|---|---|
| Relative Strength Index (RSI) | 59.04 | 74.87 |
| Support Level | $256.83 | $50.33 |
| Resistance Level | $262.76 | $52.51 |
| Average True Range (ATR) | 4.02 | 1.17 |
| MACD | 2.02 | 0.32 |
| Stochastic Oscillator | 87.55 | 100.00 |
Automatic Data Processing is a global technology company providing cloud-based human capital management solutions, enabling clients to better implement payroll, talent, time, tax, and benefits administration. Additionally, ADP provides human resource outsourcing solutions that permit customers to offload some of their traditional HR tasks. The company operates through two segments: employer services and professional employer organization services. Employer services consist of the company's HCM products as well as a la carte HRO solutions. PEO services contain ADP's comprehensive HRO solution, where it acts as a co-employer with its customer. As of fiscal 2025, ADP serves over 1.1 million clients and pays over 42 million workers across 140 countries.
Bristol-Myers Squibb discovers, develops, and markets drugs for various therapeutic areas, such as cardiovascular, cancer, and immune disorders. A key focus for Bristol is immuno-oncology, where the firm is a leader in drug development. Bristol derives close to 70% of total sales from the US, showing a higher dependence on the US market than most of its peer group.